vs
Side-by-side financial comparison of Pasithea Therapeutics Corp. (KTTA) and LQR House Inc. (YHC). Click either name above to swap in a different company.
LQR House Inc. is the larger business by last-quarter revenue ($299.7K vs $240.7K, roughly 1.2× Pasithea Therapeutics Corp.). LQR House Inc. runs the higher net margin — -1368.7% vs -2126.1%, a 757.3% gap on every dollar of revenue.
Pasithea Therapeutics Corp. is a clinical-stage biopharmaceutical firm dedicated to developing novel treatments for psychiatric and neurological conditions including treatment-resistant mood disorders. It primarily operates in North American and European markets, targeting patient segments that lack effective existing treatment options.
LQR House Inc. is a US-based alcohol beverage e-commerce and distribution company. It offers a broad portfolio of spirits, wine, and beer, operating two core segments: direct-to-consumer retail for individuals and wholesale distribution for business clients across the United States.
KTTA vs YHC — Head-to-Head
Income Statement — Q4 FY2022 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $240.7K | $299.7K |
| Net Profit | $-5.1M | $-4.1M |
| Gross Margin | — | 17.8% |
| Operating Margin | -1679.5% | -1000.3% |
| Net Margin | -2126.1% | -1368.7% |
| Revenue YoY | — | -64.2% |
| Net Profit YoY | — | 72.2% |
| EPS (diluted) | $-1.72 | $2.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $299.7K | ||
| Q3 25 | — | $337.3K | ||
| Q2 25 | — | $498.5K | ||
| Q1 25 | — | $429.3K | ||
| Q4 24 | — | $838.2K | ||
| Q3 24 | — | $624.5K | ||
| Q2 24 | — | $557.9K | ||
| Q1 24 | — | $481.1K |
| Q4 25 | — | $-4.1M | ||
| Q3 25 | — | $-16.8M | ||
| Q2 25 | — | $-2.2M | ||
| Q1 25 | — | $-2.4M | ||
| Q4 24 | — | $-14.8M | ||
| Q3 24 | — | $-3.4M | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 17.0% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | -9.9% | ||
| Q2 24 | — | -27.3% | ||
| Q1 24 | — | -16.5% |
| Q4 25 | — | -1000.3% | ||
| Q3 25 | — | -1134.8% | ||
| Q2 25 | — | -442.1% | ||
| Q1 25 | — | -559.0% | ||
| Q4 24 | — | -1221.3% | ||
| Q3 24 | — | -561.1% | ||
| Q2 24 | — | -407.7% | ||
| Q1 24 | — | -513.9% |
| Q4 25 | — | -1368.7% | ||
| Q3 25 | — | -4989.5% | ||
| Q2 25 | — | -441.8% | ||
| Q1 25 | — | -556.6% | ||
| Q4 24 | — | -1760.2% | ||
| Q3 24 | — | -538.6% | ||
| Q2 24 | — | -396.0% | ||
| Q1 24 | — | -504.6% |
| Q4 25 | — | $2.94 | ||
| Q3 25 | — | $-1.50 | ||
| Q2 25 | — | $-1.10 | ||
| Q1 25 | — | $-3.85 | ||
| Q4 24 | — | $-88.71 | ||
| Q3 24 | — | $-21.84 | ||
| Q2 24 | — | $-15.49 | ||
| Q1 24 | — | $-18.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $33.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $42.5M | $29.3M |
| Total Assets | $45.2M | $31.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $10.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $3.7M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | — | $29.3M | ||
| Q3 25 | — | $27.4M | ||
| Q2 25 | — | $12.2M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $-518.0K | ||
| Q3 24 | — | $9.1M | ||
| Q2 24 | — | $11.7M | ||
| Q1 24 | — | $12.4M |
| Q4 25 | — | $31.2M | ||
| Q3 25 | — | $35.0M | ||
| Q2 25 | — | $14.4M | ||
| Q1 25 | — | $9.6M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | — | $9.8M | ||
| Q2 24 | — | $12.2M | ||
| Q1 24 | — | $12.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.4M | $-14.3M |
| Free Cash FlowOCF − Capex | $-4.5M | — |
| FCF MarginFCF / Revenue | -1874.2% | — |
| Capex IntensityCapex / Revenue | 38.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-14.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-14.3M | ||
| Q3 25 | — | $-11.3M | ||
| Q2 25 | — | $-1.6M | ||
| Q1 25 | — | $-6.6M | ||
| Q4 24 | — | $-3.1M | ||
| Q3 24 | — | $-1.0M | ||
| Q2 24 | — | $-1.2M | ||
| Q1 24 | — | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -287.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
